Cullinan Therapeutics Inc.

NASDAQ: CGEM
Share price (3/21/25): $8.52
Market cap (3/21/25): $499 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Shelf registration

Registration of securities for employees

Shelf registration – amended

Ownership Filter

Jones Jeffrey Alan

Michaelson Jennifer

Sumer Jacquelyn L

Michaelson Jennifer

News Filter

Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Material Disclosure, Other Events, Financial Statements or Exhibits

Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients With Moderate to Severe Systemic Lupus Erythematosus

Receives Approval to Initiate Its Global Phase 1 Clinical Trial of CLN-978 for the Treatment of Systemic Lupus Erythematosus

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness